» Articles » PMID: 15226391

Localization and Regulation of SR-BI in Membrane Rafts of HepG2 Cells

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2004 Jul 1
PMID 15226391
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The scavenger receptor class B, type I (SR-BI) mediates cholesteryl esters (CE) selective uptake from low density lipoprotein (LDL) and high-density lipoprotein (HDL) particles. In a number of tissues expressing caveolin, SR-BI is localized in caveolae. We show using detergent-free sucrose gradients that SR-BI is found in membrane rafts devoid of caveolin-1 in the human hepatoma HepG2 cell. Perturbation of the structure of HepG2 cell membrane rafts with cholesterol oxidase or sphingomyelinase decreased LDL-CE association due to selective uptake by 60%, while HDL3-CE selective uptake was increased 2.3-fold by cholesterol oxidase but was not affected by sphingomyelinase. Sequestration of membrane cholesterol with filipin III decreased LDL-CE selective uptake by 25%, while it had no effect on HDL3-CE selective uptake. Extraction of cell membrane cholesterol with beta-cyclodextrin increased LDL- and HDL3-CE selective uptake by 1.6-fold and 3-fold, respectively. We found that CE-selective uptake from both HDL and LDL occurs by a pathway involving retro-endocytosis in HepG2 cells. An analysis of the effect of SR-BI level on the expression of critical lipid sensor and lipid binding proteins was conducted with stable transformants of HepG2 cell overexpressing SR-BI. We found that liver-type fatty acid binding protein expression level is higher in SR-BI-overexpressing cells and that caveolin-1 and sterol response element binding protein-2 levels are reduced. Thus, in this hepatic cell model, SR-BI is associated with membrane rafts devoid of caveolin and its expression affects intracellular lipid binding and lipid sensor proteins. SR-BI-dependent LDL- and HDL-CE selective uptake are affected differently by the integrity of membrane rafts, but both occur by a retroendocytic pathway in HepG2 cells.

Citing Articles

Mitigating Vascular Inflammation by Mimicking AIBP Mechanisms: A New Therapeutic End for Atherosclerotic Cardiovascular Disease.

Kim J, Jain A, Fang L Int J Mol Sci. 2024; 25(19).

PMID: 39408645 PMC: 11477018. DOI: 10.3390/ijms251910314.


The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD.

Astorga J, Gasaly N, Dubois-Camacho K, De la Fuente M, Landskron G, Faber K Front Immunol. 2022; 13:1028953.

PMID: 36466902 PMC: 9716353. DOI: 10.3389/fimmu.2022.1028953.


Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses.

Lam S, Huang X, Shui G Trends Endocrinol Metab. 2022; 33(8):554-568.

PMID: 35613979 PMC: 9058057. DOI: 10.1016/j.tem.2022.04.011.


Sphingolipids and Cholesterol.

Jiang X, Li Z Adv Exp Med Biol. 2022; 1372:1-14.

PMID: 35503170 PMC: 9251731. DOI: 10.1007/978-981-19-0394-6_1.


Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds.

Liou J, Mani H, Yen J Int J Mol Sci. 2022; 23(7).

PMID: 35409259 PMC: 8999150. DOI: 10.3390/ijms23073897.